Alnylam Pharmaceuticals
Kathleen Murphy-Frenette RN BSN has extensive experience in patient education and case management within the healthcare sector. Currently serving as a Patient Education Liaison at Alnylam Pharmaceuticals since March 2021, Kathleen previously worked as a Rare Disease Field Educator in Neurology at Alexion Pharmaceuticals, where responsibilities included enrolling patients in personalized support programs and facilitating patient education. Prior roles include RN Field Case Manager at Workers Compensation Trust, overseeing medical services for injured patients, and RN Case Manager at Connecticut Community Care, Inc., managing elder care services. Kathleen holds a Bachelor’s degree in Nursing Science from Chamberlain University and certifications from the Case Management Society of America.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.